About Spectrum Antimicrobials
Spectrum Antimicrobials is a private company based in Petaluma, California. It has reported $30,240,000 raised in two offerings on Form D since April 2020. Its chief executive is Hojabr Alimi.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Jul 25, 2022 | Sep 16, 2024 | $3,855,000of $4.0M target | 28 | $137K | Equity, DebtRule 506(b) | Form D ↗ |
| Mar 21, 2020 | Apr 8, 2020amended Apr 1, 2026 | $26,385,000of $35.0M target | 247 | $106K | EquityRule 506(c) | Form D/A ↗6 earlier filings |
| Total, two offerings | $30,240,000 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Spectrum Antimicrobials's Form D filed Sep 16, 2024.
KL
Kate Lewis
Director
DA
David Allie
Director
SS
Steven Solferino
Director
WI
HA
Hojabr Alimi
CEO and director
JS
Jerry Stonemetz
Executive officer
Earlier filings also listed Sameer Harish (executive officer, last listed Sep 2024).
Sources
- SECSpectrum Antimicrobials, Inc. Form D/A, filed Oct 22, 2024
- SECSpectrum Antimicrobials, Inc. Form D/A, filed Sep 13, 2024
- SECSpectrum Antimicrobials, Inc. Form D/A, filed Apr 1, 2022
- SECSpectrum Antimicrobials, Inc. Form D/A, filed Apr 2, 2021
- SECSpectrum Antimicrobials, Inc. Form D/A, filed Jun 10, 2020
- SECSpectrum Antimicrobials, Inc. Form D, filed Apr 8, 2020
- SECSpectrum Antimicrobials, Inc. filing history
- CompanyContact